Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-877-ER vs K-877-IR in Patients with Hypertriglyceridemia
NCT04447820Phase 2Completed
- Start
- Jun 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemafibrate in hypertriglyceridemia, dyslipidemia. Started Jun 2020; status: completed.
02
Drugs
pemafibrate
03
Conditions
hypertriglyceridemiadyslipidemia
Beyond the preview
Go deeper on NCT04447820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04447820.